BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 7975484)

  • 1. [Removal of leukocytes from preserved blood using a simple filtration method which utilizes silon made in Czechoslovakia].
    Fiala J
    Vnitr Lek; 1980; 26(5):500-5. PubMed ID: 7395125
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole blood leukocytes isolation with microfabricated filter for cell analysis.
    Yu L; Warner P; Warner B; Recktenwald D; Yamanishi D; Guia A; Ghetti A
    Cytometry A; 2011 Dec; 79(12):1009-15. PubMed ID: 22110022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
    Chamfly V
    Transfus Sci; 1998 Dec; 19(4):333-42. PubMed ID: 10351148
    [No Abstract]   [Full Text] [Related]  

  • 4. Canadian Red Cross Society symposium on leukodepletion: report of proceedings.
    Freedman JJ; Blajchman MA; McCombie N
    Transfus Med Rev; 1994 Jan; 8(1):1-14. PubMed ID: 7907899
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte-poor blood products: filtration mechanisms.
    Steneker I
    Vox Sang; 1994; 67 Suppl 3():159-60. PubMed ID: 7975484
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukocyte filtration mechanisms. Factors influencing the removal of infectious agents from red cell concentrates.
    Steneker I; Pietersz RN; Reesink HW
    Immunol Invest; 1995; 24(1-2):87-93. PubMed ID: 7713608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on leucocyte depletion of blood components by filtration.
    Pietersz RN; van der Meer PF; Seghatchian MJ
    Transfus Sci; 1998 Dec; 19(4):321-8. PubMed ID: 10351145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contamination control in nursing with filtration: part 2: emerging rationale for bedside (final) filtration of prestorage leukocyte-reduced blood products.
    Ortolano GA; Russell RL; Angelbeck JA; Schaffer J; Wenz B
    J Infus Nurs; 2004; 27(3):157-65. PubMed ID: 15118453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of white cell-poor blood components.
    Snyder EL
    Transfusion; 1989 Sep; 29(7):568-71. PubMed ID: 2672432
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte separation and transfusion].
    Kretschmer V
    Beitr Infusionther Klin Ernahr; 1981; 6():1-189. PubMed ID: 7020691
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.